Reply to “Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas”

Head & NeckVolume 41, Issue 8 p. 2837-2838 LETTER TO THE EDITOR Reply to “Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas” Yasmin Lassen-Ramshad MD, PhD, Corresponding Author Yasmin Lassen-Ramshad MD, PhD yasmin.lassen@auh.rm.dk orcid.org/0000-0002-4992-3231 Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark Department of Oncology, Aarhus University Hospital, Aarhus, Denmark Correspondence Yasmin Lassen-Ramshad, Aarhus University Hospital, Aarhus, Denmark. Email: yasmin.lassen@auh.rm.dkSearch for more papers by this authorEnis Ozyar MD, Enis Ozyar MD Acibadem M.A. Aydinlar University, School of Medicine, Department of Radiation Oncology, TurkeySearch for more papers by this authorSenem Alanyali MD, Senem Alanyali MD Department of Radiation Oncology, Faculty of Medicine, Ege University, TurkeySearch for more papers by this authorPhilip Poortmans MD, PhD, Philip Poortmans MD, PhD Department of Radiation Oncology, Institut Curie, Paris, FranceSearch for more papers by this authorPaul Van Houtte MD, PhD, Paul Van Houtte MD, PhD Department of Radiation Oncology, Jules Bordet Institute, Brussels, BelgiumSearch for more papers by this authorSchoeb Sohawon MD, MSc, Schoeb Sohawon MD, MSc Department of Radiation Oncology, Jules Bordet Institute, Brussels, BelgiumSearch for more papers by this authorMustafa Esassolak MD, Mustafa Esassolak MD Department of Radiation Oncology, Faculty of Medicine, Ege University, TurkeySearch for more papers by this authorMarco Krengli MD, Marco Krengli MD Department of Radiotherapy, University of Piemonte Orientale, Novara, ItalySearch for more papers by this authorSalvador Villa MD, Salvador Villa MD Department of Radiation Oncology, Catalan Institute of Oncology, Badalona, SpainSearch for more papers by this authorRobert C. Miller MD, MS, Robert C. Miller MD, MS Department of Radiation Oncology, Mayo Clinic, Jacksonville, FloridaSearch for more papers by this authorCandan Demiroz MD, Candan Demiroz MD Uludag University Faculty of Medicine, Radiation Oncology Clinical Division, TurkeySearch for more papers by this authorSerap Akyurek MD, PhD, Serap Akyurek MD, PhD Department of Radiotherapy, Ankara University School of Medicine, Ankara, TurkeySearch for more papers by this authorNinna Aggerholm-Pedersen MD, PhD, Ninna Aggerholm-Pedersen MD, PhD Department of Oncology, Aarhus University Hospital, Aarhus, DenmarkSearch for more papers by this authorJuliette Thariat MD, PhD, Juliette Thariat MD, PhD Radiation Oncology Department, Centre Francois Baclesse, Caen, FranceSearch for more papers by this author Yasmin Lassen-Ramshad MD, PhD, Corresponding Author Yasmin Lassen-Ramshad MD, PhD yasmin.lassen@auh.rm.dk orcid.org/0000-0002-4992-3231 Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark Department of Oncology, Aarhus University Hospital, Aarhus, Denmark Correspondence Yasmin Lassen-Ramshad, Aarhus University Hospital, Aarhus, Denmark. Email: yasmin.lassen@auh.rm.dkSearch for more papers by this authorEnis Ozyar MD, Enis Ozyar MD Acibadem M.A. Aydinlar University, School of Medicine, Department of Radiation Oncology, TurkeySearch for more papers by this authorSenem Alanyali MD, Senem Alanyali MD Department of Radiation Oncology, Faculty of Medicine, Ege University, TurkeySearch for more papers by this authorPhilip Poortmans MD, PhD, Philip Poortmans MD, PhD Department of Radiation Oncology, Institut Curie, Paris, FranceSearch for more papers by this authorPaul Van Houtte MD, PhD, Paul Van Houtte MD, PhD Department of Radiation Oncology, Jules Bordet Institute, Brussels, BelgiumSearch for more papers by this authorSchoeb Sohawon MD, MSc, Schoeb Sohawon MD, MSc Department of Radiation Oncology, Jules Bordet Institute, Brussels, BelgiumSearch for more papers by this authorMustafa Esassolak MD, Mustafa Esassolak MD Department of Radiation Oncology, Faculty of Medicine, Ege University, TurkeySearch for more papers by this authorMarco Krengli MD, Marco Krengli MD Department of Radiotherapy, University of Piemonte Orientale, Novara, ItalySearch for more papers by this authorSalvador Villa MD, Salvador Villa MD Department of Radiation Oncology, Catalan Institute of Oncology, Badalona, SpainSearch for more papers by this authorRobert C. Miller MD, MS, Robert C. Miller MD, MS Department of Radiation Oncology, Mayo Clinic, Jacksonville, FloridaSearch for more papers by this authorCandan Demiroz MD, Candan Demiroz MD Uludag University Faculty of Medicine, Radiation Oncology Clinical Division, TurkeySearch for more papers by this authorSerap Akyurek MD, PhD, Serap Akyurek MD, PhD Department of Radiotherapy, Ankara University School of Medicine, Ankara, TurkeySearch for more papers by this authorNinna Aggerholm-Pedersen MD, PhD, Ninna Aggerholm-Pedersen MD, PhD Department of Oncology, Aarhus University Hospital, Aarhus, DenmarkSearch for more papers by this authorJuliette Thariat MD, PhD, Juliette Thariat MD, PhD Radiation Oncology Department, Centre Francois Baclesse, Caen, FranceSearch for more papers by this author First published: 06 May 2019 https://doi.org/10.1002/hed.25800Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume41, Issue8August 2019Pages 2837-2838 RelatedInformation